Simon Thezenas

Simon Thezenas

UNVERIFIED PROFILE

Are you Simon Thezenas?   Register this Author

Register author
Simon Thezenas

Simon Thezenas

Publications by authors named "Simon Thezenas"

Are you Simon Thezenas?   Register this Author

49Publications

645Reads

-Profile Views

The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases.

BMC Cancer 2019 Jan 30;19(1):110. Epub 2019 Jan 30.

Laboratoire de Biochimie et Protéomique Clinique, University of Montpellier, Institute of Regenerative Medicine - Biotherapy IRMB, CHU Montpellier, INSERM, 80 Avenue Augustin Fliche, 34295, Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-019-5287-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354387PMC
January 2019

Sunitinib Alone or after Nephrectomy in Renal Cancer.

N Engl J Med 2018 11;379(19):1878

Université Paris–Descartes, Paris, France

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMc1811532
Publisher Site
http://dx.doi.org/10.1056/NEJMc1811532DOI Listing
November 2018

Granulocyte-colony stimulating factor enhances bone fracture healing.

Clin Biomech (Bristol, Avon) 2018 Oct 20;58:62-68. Epub 2018 Jul 20.

Aix Marseille Univ, CNRS, ISM, Inst Movement Sci, Marseille, France; APHM, Hôpital Sainte Marguerite, IML, Marseille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinbiomech.2018.07.010DOI Listing
October 2018

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.

N Engl J Med 2018 Aug 3;379(5):417-427. Epub 2018 Jun 3.

From the Departments of Urology (A.M., M.-O.T.) and Medical Oncology (S.O.), Hôpital Européen Georges-Pompidou, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris-Descartes, and Paris Descartes Necker-Cochin Clinical Research Unit, AP-HP (S.C.), Paris, the Department of Medical Oncology, Bordeaux University Hospital (A.R.), the Department of Medical Oncology, Hôpital Saint André, Centre Hospitalier Universitaire (CHU) de Bordeaux (M.G.-G.), and the Department of Urology, CHU de Bordeaux and Université de Bordeaux (J.-C.B.), Bordeaux, Biometrics Unit, Cancer Institute of Montpellier, University of Montpellier, Montpellier (S.T.), the Department of Urology, CHU Rangueil (J.-B.B.), and the Department of Medical Oncology, Institut Universitaire du Cancer Toulouse-Oncopole (C.C.), Toulouse, the Department of Urology, University of Rennes (K.B.), and the Department of Medical Oncology, Centre Eugene Marquis (B.L.), Rennes, the Department of Medical Oncology, Institut de Cancerologie de Lorraine, Vandoeuvre lès Nancy (L. Geoffrois), the Department of Medical Oncology, CHU Besançon, Oncologie, and Université de Franche-Comte, INSERM Unité Mixte de Recherche (UMR) 1098, Structure Fédérative de Recherche Ingénierie et Biologie Cellulaire et Tissulaire, Besançon (A.T.-V.), the Department of Urology, CHU François Mitterrand, Dijon (L.C.), the Department of Urology, CHU Strasbourg, Translational Medicine Federation Strasbourg, Strasbourg (H.L.), the Department of Urology, Gabriel Montpied Hospital, and Clermont Auvergne University, Clermont-Ferrand (L. Guy), the Department of Medical Oncology, Centre de Recherche en Cancerologie de Marseille, INSERM UMR 1068, Centre National de la Recherche Scientifique UMR 7258 and Institut Paoli-Calmettes (G.G.), and the Department of Urology, Hôpital la Conception (E.L.), Aix Marseille Université, Marseille, the Department of Medical Oncology, Institut de Cancerologie de l'Ouest, Nantes (F.R.), the Department of Medical Oncology, CHU Bretonneau, and the Department of Medicine, Université François Rabelais, Tours (C.L.), the Department of Urology, Mont de Marsan General Hospital, Mont de Marsan (J.-J.P.), the Departments of Medical Oncology (C.T.) and Urology (T.L.), Hôpital Foch, Suresnes, the Department of Urology, Imagerie Adaptative Diagnostique et Interventionnelle INSERM Unité 1254, CHU de Nancy, Brabois (J.H.), the Department of Medical Oncology, Institut Gustave Roussy and Université Paris-Saclay, Villejuif (L.A., B.E.), and Université Versailles, St.-Quentin-en-Yvelines (T.L.) - all in France; the Department of Urology, Haukeland University Hospital (C.B.), and the Department of Clinical Medicine, University of Bergen (C.B.), Bergen, Norway; and the Department of Urology, Royal Free Hospital, London (M.A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1803675DOI Listing
August 2018

Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective study.

BMC Cancer 2018 Jul 30;18(1):770. Epub 2018 Jul 30.

Department of Medical Oncology, Institut Régional Du Cancer de Montpellier ICM, 208 Avenue des Apothicaires, Cedex-5 34298, Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-4686-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066931PMC
July 2018

Assessing dietary intake in accordance with guidelines: Useful correlations with an ingesta-Verbal/Visual Analogue Scale in medical oncology patients.

Clin Nutr 2018 Jun 30. Epub 2018 Jun 30.

Department of Supportive Care, Cancer Institute of Montpellier (ICM), Montpellier, University of Montpellier, France; Department of Clinical Nutrition and Gastroenterology, Cancer Institute of Montpellier (ICM), University of Montpellier, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S02615614183119
Publisher Site
http://dx.doi.org/10.1016/j.clnu.2018.06.974DOI Listing
June 2018

Serum Vitamin D Levels Affect Pathologic Complete Response in Patients Undergoing Neoadjuvant Systemic Therapy for Operable Breast Cancer.

Clin Breast Cancer 2018 04 11;18(2):144-149. Epub 2017 Dec 11.

Department of Medical Oncology, Institut Régional Du Cancer de Montpellier ICM, Montpellier, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2017.12.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140343PMC
April 2018

Prognostic impact of the inclusion of uPA/PAI-1 for adjuvant treatment decision-making in ER+/Her2- pN0 early breast cancers.

Breast Cancer Res Treat 2017 Oct 6;165(3):611-621. Epub 2017 Jul 6.

Institut Régional du Cancer de Montpellier - Val d'Aurelle, 208 avenue des Apothicaires, 34298, Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4373-7DOI Listing
October 2017

Serum NSE, MMP-9 and HER2 extracellular domain are associated with brain metastases in metastatic breast cancer patients: predictive biomarkers for brain metastases?

Int J Cancer 2016 11 6;139(10):2299-311. Epub 2016 Aug 6.

Department of Medical Oncology, Institut Régional Du Cancer Montpellier ICM, Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.30290DOI Listing
November 2016

Meal context and food preferences in cancer patients: results from a French self-report survey.

Springerplus 2016 21;5(1):810. Epub 2016 Jun 21.

SIRIC Montpellier Cancer, Cancer Institute of Montpellier (ICM)-Val d'Aurelle, 208 avenue des Apothicaires, Parc Euromédecine, 34298 Montpellier Cedex 5, France ; Epsylon Research Unit EA 4556 Laboratory, Departments of Sport Sciences, Medicine and Psychology, University of Montpellier and University Paul Valery, Rue du Pr. Henri Serre, 34000 Montpellier, France ; Department of Clinical Nutrition and Gastroenterology, Cancer Institute of Montpellier (ICM), Val d'Aurelle, 208 avenue des Apothicaires, Parc Euromédecine, 34298 Montpellier Cedex 5, France ; Group of Nutrition and Dietary Committees of Anti-Cancer Centers (Interclan CLCC), Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40064-016-2538-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916076PMC
July 2016

Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases.

Breast Cancer Res Treat 2016 06 11;157(2):307-318. Epub 2016 May 11.

Medical Oncology Department, Institut Claudius Regaud, IUCT-Oncopole, 1 avenue Irène Joliot-Curie, 31059, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3828-6DOI Listing
June 2016

Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer.

Clin Transl Med 2014 28;3:31. Epub 2014 Oct 28.

Department of Biology and Oncogenetics, Institut Régional du Cancer de Montpellier (ICM), Val d¿Aurelle, Montpellier, 34298, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40169-014-0031-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410142PMC
May 2015

Bone metastases in gastrointestinal cancer.

Clin Exp Metastasis 2015 Jan 9;32(1):7-14. Epub 2014 Nov 9.

Department of Digestive Oncology, Institut régional du Cancer de Montpellier (ICM) - Val d'Aurelle, 208 avenue des Apothicaires, 34298, Montpellier Cedex 5, France,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10585-014-9686-xDOI Listing
January 2015

Prognostic factors of brain metastases from breast cancer: impact of targeted therapies.

Breast 2013 Oct 3;22(5):993-8. Epub 2013 Jul 3.

Department of Radiation Oncology, Val d'Aurelle Cancer Institute, 208 rue des Apothicaires, 34298 Montpellier, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2013.05.011DOI Listing
October 2013

Comparative performances of prognostic indexes for breast cancer patients presenting with brain metastases.

BMC Cancer 2013 Feb 8;13:70. Epub 2013 Feb 8.

Department of Radiation Oncology, Val d'Aurelle Cancer Institute, 208 rue des apothicaires, Montpellier 34298, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-13-70DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599004PMC
February 2013

Immunonutrition before and during radiochemotherapy: improvement of inflammatory parameters in head and neck cancer patients.

Support Care Cancer 2012 Dec 28;20(12):3129-35. Epub 2012 Mar 28.

Department of Biochemistry, Lapeyronie Hospital, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-012-1444-5DOI Listing
December 2012

Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy.

Breast Cancer Res Treat 2012 Jul 6;134(2):709-17. Epub 2012 May 6.

Département d'Oncologie Médicale, CRLC Val d'Aurelle-Paul Lamarque, 208, rue des Apothicaires, 34298 Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-012-2084-7DOI Listing
July 2012

Systemic chemotherapy in patients with advanced transitional cell carcinoma of the urothelium and impaired renal function.

Anticancer Drugs 2012 Feb;23(2):143-8

Department of Medical Oncology, University Hospital, Nîmes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0b013e32834c2ab6DOI Listing
February 2012

Prophylactic percutaneous endoscopic gastrostomy in patients with advanced head and neck tumors treated by combined chemoradiotherapy.

J Pain Symptom Manage 2011 Oct 7;42(4):548-56. Epub 2011 Apr 7.

Department of Gastro-Nutrition, Val d'Aurelle Cancer Institute, Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpainsymman.2011.01.009DOI Listing
October 2011

CIP2A is associated with human breast cancer aggressivity.

Clin Cancer Res 2009 Aug 11;15(16):5092-100. Epub 2009 Aug 11.

Centre for Biotechnology, University of Turku, Turku, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-3283DOI Listing
August 2009

Prognostic significance of TRAIL-R1 and TRAIL-R3 expression in metastatic colorectal carcinomas.

Eur J Cancer 2008 Oct 26;44(15):2312-8. Epub 2008 Aug 26.

Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM, U896, Université Montpellier1, CRLC Val d'Aurelle Paul Lamarque, 208 rue des Apothicaires, F-34298 Montpellier Cedex 5, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2008.06.042DOI Listing
October 2008

Cyclin D1 gene G870A polymorphism predicts response to neoadjuvant radiotherapy and prognosis in rectal cancer.

Int J Radiat Oncol Biol Phys 2007 Jul 29;68(4):1094-101. Epub 2007 Mar 29.

INSERM U860, and Department of Oncobiology, Val d'Aurelle Cancer Institute, 208 rue des Apothicaires, 34298 Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2007.01.022DOI Listing
July 2007

[Positive sentinel node biopsy in breast cancer: is axillary surgery necessary in all cases?].

Bull Cancer 2007 Jul;94(7):700-4

Service de chirurgie, CRLC Val d'Aurelle-Paul Lamarque, 208, rue des Apothicaires, Parc Euromédecine, 34298 Montpellier Cedex 5.

View Article

Download full-text PDF

Source
July 2007

In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomas.

Clin Cancer Res 2007 Jun;13(11):3356-62

Institut National de la Santé et de la Reserche Médicale, EMI 0227, Centre de Recherche en cancérologie de Montpellier, Université Montpellier I, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-2302DOI Listing
June 2007

Increased expression of fatty acid synthase and progesterone receptor in early steps of human mammary carcinogenesis.

Int J Cancer 2007 Jan;120(2):224-9

Endocrinologie Moléculaire et Cellulaire des Cancers (U540), Institut National de la Santé et de la Recherche Médicale (INSERM), 34090 Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.22202DOI Listing
January 2007

Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic results.

Int J Radiat Oncol Biol Phys 2006 Apr 25;64(5):1410-5. Epub 2006 Jan 25.

Department of Radiation Oncology, Val d'Aurelle Cancer Institute, Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2005.10.025DOI Listing
April 2006

Hepatic metastases from carcinomas of unknown primary site.

Gastroenterol Clin Biol 2005 Dec;29(12):1224-32

Département d'Oncologie Médicale, Centre Régional de Lutte contre le Cancer Val d'Aurelle, Parc Euromédecine, 34298 Montpellier Cedex 5.

View Article

Download full-text PDF

Source
December 2005

Inter- and intra-individual variability in transdermal fentanyl absorption in cancer pain patients.

Oncol Rep 2005 Oct;14(4):1029-36

Oncopharmacology Laboratory, Val d'Aurelle Anticancer Centre, Parc Euromédecine, Montpellier, France.

View Article

Download full-text PDF

Source
October 2005

Interest of investigating p53 status in breast cancer by four different methods.

Oncol Rep 2002 Nov-Dec;9(6):1167-72

CRLC Val d'Aurelle Paul-Lamarque, Cancer research center, Parc Euromedecine, 34298 Montpellier, Cedex 5, France.

View Article

Download full-text PDF

Source
March 2003

Progesterone receptor quantification as a strong prognostic determinant in postmenopausal breast cancer women under tamoxifen therapy.

Breast Cancer Res Treat 2002 Nov;76(1):65-71

Laboratoire d'Oncobiologie, CRLC Val d'Aurelle, Montpellier, France.

View Article

Download full-text PDF

Source
November 2002